Skip to content

Drug interactions

Ciltacabtagene autoleucel + Tocilizumab

Severity: Moderate

Ciltacabtagene autoleucel and Tocilizumab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tocilizumab is used to treat cytokine release syndrome after CAR-T therapy, so use together is expected. Prophylactic or prolonged use may reduce CAR-T efficacy and increases infection risk.

What this interaction means in plain words

Ciltacabtagene autoleucel and Tocilizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ciltacabtagene autoleucel belongs to Miscellaneous; Tocilizumab belongs to Musculoskeletal.

Evidence level: Moderate

Why it happens

IL-6 receptor blockade adds immunosuppression and may dampen CAR-T cell activation and expansion.

What to do

Use tocilizumab for CRS per the labeled algorithm rather than prophylactically. Monitor for infection.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ciltacabtagene autoleucel and Tocilizumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ciltacabtagene autoleucel with Tocilizumab?

MediHelp rates the interaction as moderate. Ciltacabtagene autoleucel and Tocilizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tocilizumab is used to treat cytokine release syndrome after CAR-T therapy, so use together is expected. Prophylactic or prolonged use may reduce CAR-T efficacy and increases infection risk.

How serious is the interaction between Ciltacabtagene autoleucel and Tocilizumab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Use tocilizumab for CRS per the labeled algorithm rather than prophylactically. Monitor for infection.

What other medicines interact with Tocilizumab?

MediHelp also lists interactions of Tocilizumab with, for example, Bcg vaccine live, Measles mumps and rubella vaccine live, Measles mumps rubella and varicella vaccine live. The full list is on the Tocilizumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in